Review focus on the role of microRNA in cardiovascular biology and disease

Cardiovascular Research

Volumn 93, Issue 4, 2012, Pages 543-544

  Thum, Thomas ^a,b   Mayr, Manuel ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; EDITORIAL; GENE TECHNOLOGY; HEART VENTRICLE HYPERTROPHY; HUMAN; PRIORITY JOURNAL; RNA ANALYSIS;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; DISEASE MODELS, ANIMAL; HUMANS; MICRORNAS; MYOCYTES, CARDIAC; SIGNAL TRANSDUCTION;

EID: 84857980785     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs085     Document Type: Editorial

References (20)

1. Zampetaki A, Mayr M. MicroRNAs in vascular and metabolic diseases. Circ Res 2012; 110:508-522.
2. Thum T. MicroRNA therapeutics in cardiovascular medicine. EMBO Mol Med 2012;4:3-14.
3. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005;436:214-220. (Pubitemid 41021266)
4. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 2006;103:18255-18260. (Pubitemid 44871645)
5. Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 2011;51:872-875.
6. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008;456:980-984.
7. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009;324:1710-1713.
8. Dangwal S, Bang C, Thum T. Novel techniques and targets in cardiovascular micro-RNA research. Cardiovasc Res 2012;93:545-554.
9. Zampetaki A, Willeit P, Drozdov I, Kiechl S, Mayr M. Profiling of circulating micro-RNAs: from single biomarkers to re-wired networks. Cardiovasc Res 2012;93: 555-562.
10. Diehl P, Fricke A, Sander L, Stamm J, Bassler N, Htun N et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 2012;93: 633-644.
11. Da Costa Martins PA, De Windt LJ. MicroRNAs in control of cardiac hypertrophy. Cardiovasc Res 2012;93:563-572.
12. Han M, Yang Z, Sayed D, He M, Gao S, Lin L et al. GATA4 expression is primarily regulated via an miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy. Cardiovasc Res 2012;93:645-654.
13. Tijsen AJ, Pinto YM, Creemers EE. Non-cardiomyocyte microRNAs in heart failure. Cardiovasc Res 2012;93:573-582.
14. Shantikumar S, Caporali A, Emanueli C. Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res 2012;93:583-593.
15. McDonald RA, Hata A, MacLean M, Morrell NW, Baker AH. MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling. Cardiovasc Res 2012;93:594-604.
16. Schroen B, Heymans S. Small but smart-microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing. Cardiovasc Res 2012;93:605-613.
17. Jakob P, Landmesser U. Role of microRNAs in stem/progenitor cells and cardiovascular repair. Cardiovasc Res 2012;93:614-622.
18. Pfaff N, Fiedler J, Holzmann A, Schambach A, Moritz T, Cantz T et al. miRNA screening reveals a new miRNA family stimulating iPS cell generation via regulation of Meox2. EMBO Rep 2011;12:1153-1159.
19. Ruan W, Xu J, Li S, Yuan L, Dai R. Effects of down-regulation of microRNA-23a on TNF-a-induced endothelial cell apoptosis through caspase-dependent pathways. Cardiovasc Res 2012;93:623-632.
20. van Mil A, Grundmann S, Goumans MJ, Lei Z, Oerlemans MI, Jaksani S et al. MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release. Cardiovasc Res 2012;93:655-665.